17 days ago
PODD
AnalystsWilliam PlovanicWilliam Plovanic's Stock Forecasts
AnalystsWilliam Plovanic
Analyst Ranking
Top 11%
#547 out of 5143 analysts
Average Return
+9.37%
Win Rate
50%83 out of 165
Risk vs Reward
Poor
Good
William Plovanic's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Neuronetics IncSTIM | +422.33% | $0.74 | $3.86 | 2024-08-12 - 2025-08-12 | Strong Buy |
Transmedics Group IncTMDX | +243.26% | $22.17 | $76.10 | 2022-03-16 - 2023-03-16 | Strong Buy |
Irhythm Technologies IncIRTC | +139.28% | $72.69 | $173.93 | 2024-09-24 - 2025-09-24 | Strong Buy |
Bioventus IncBVS | +128.57% | $5.11 | $11.68 | 2023-12-06 - 2024-12-06 | Strong Buy |
Irhythm Technologies IncIRTC | +109.36% | $82.79 | $173.33 | 2024-12-08 - 2025-12-08 | Strong Buy |
William Plovanic Analyst Color
Get additional color on William Plovanic's coverage of popular stocks
a month ago
HTFL
a month ago
PODD
a month ago
AORT
a month ago
IRTC
2 months ago
ANGO
2 months ago
BSX
2 months ago
IRTC
2 months ago
AORT
2 months ago
PODD
3 months ago
HTFL
4 months ago
PODD
4 months ago
AORT
4 months ago
IRTC
5 months ago
ANGO
5 months ago
TMDX
7 months ago
DXCM
9 months ago
STIM
10 months ago
DXCM
10 months ago
ATRC
10 months ago
CVRX
a year ago
PODD
a year ago
IRTC
a year ago
CVRX
a year ago
CBLL
William Plovanic's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Edwards Lifesciences CorpEW | 26 | Hold | $89.00 | +6.05% | Maintains | 6 days ago |
Insulet CorpPODD | 7 | Strong Buy | $432.00 | +46.35% | Maintains | 17 days ago |
Heartflow IncHTFL | 3 | Strong Buy | $40.00 | +42.50% | Maintains | a month ago |
Artivion IncAORT | 4 | Strong Buy | $51.00 | +15.36% | Maintains | a month ago |
Cvrx IncCVRX | 9 | Strong Buy | $11.00 | +30.33% | Maintains | a month ago |
Irhythm Technologies IncIRTC | 13 | Strong Buy | $212.00 | +22.99% | Maintains | a month ago |
Dexcom IncDXCM | 9 | Strong Buy | $99.00 | +46.54% | Maintains | a month ago |
Transmedics Group IncTMDX | 8 | Strong Buy | $147.00 | +12.03% | Maintains | a month ago |
Atricure IncATRC | 12 | Strong Buy | $64.00 | +55.42% | Maintains | a month ago |
Boston Scientific CorpBSX | 12 | Strong Buy | $132.00 | +42.39% | Maintains | 2 months ago |
Angiodynamics IncANGO | 8 | Strong Buy | $18.00 | +35.14% | Maintains | 2 months ago |
Tandem Diabetes Care IncTNDM | 6 | Strong Buy | $24.00 | +11.89% | Maintains | 2 months ago |
Neuronetics IncSTIM | 4 | Strong Buy | $7.00 | +426.32% | Maintains | 4 months ago |
Globus Medical IncGMED | 4 | Strong Buy | $90.00 | +2.48% | Maintains | 5 months ago |
Zimmer Biomet Holdings IncZBH | 3 | Hold | $101.00 | +8.50% | Maintains | 7 months ago |
Trisalus Life Sciences IncTLSI | 4 | Strong Buy | $11.00 | +51.72% | Maintains | 8 months ago |
Ceribell IncCBLL | 4 | Strong Buy | $33.00 | +63.53% | Maintains | 9 months ago |
Nevro CorpNVRO | 12 | Hold | $5.85 | +0.17% | Maintains | 10 months ago |
Inari Medical IncNARI | 12 | Hold | $80.00 | +0.04% | Downgrades | a year ago |
Bioventus IncBVS | 4 | Strong Buy | $15.00 | N/A | Maintains | a year ago |
Shockwave Medical IncSWAV | 6 | Hold | $335.00 | N/A | Downgrades | 2 years ago |
Penumbra IncPEN | 4 | Strong Buy | $284.00 | N/A | Reiterates | 2 years ago |
Alphatec Holdings IncATEC | 1 | Strong Buy | $25.00 | N/A | Maintains | 2 years ago |
Pulmonx CorpLUNG | 4 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Merit Medical Systems IncMMSI | 4 | Hold | $70.00 | N/A | Maintains | 2 years ago |
Staar Surgical CoSTAA | 5 | Hold | $48.00 | N/A | Downgrades | 2 years ago |
Y Mabs Therapeutics IncYMAB | 3 | Strong Buy | $22.00 | N/A | Maintains | 2 years ago |
Vapotherm IncVAPO | 2 | Hold | $40.00 | N/A | Downgrades | 4 years ago |
Acutus Medical IncAFIB | 4 | Hold | $3.00 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.